Humacyte (HUMA) EBITDA Margin (2020 - 2026)
Humacyte's EBITDA Margin was -6319.95% in Q2 2026, up 3124.24 percentage points from -9444.19% a year earlier but down 745.61 percentage points from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Humacyte's EBITDA Margin was -4990.57% through Jun 30, 2026, up 7974.83 percentage points year-over-year; for FY2025, it was -5044.60%.
- Quarterly EBITDA Margin has moved between -9444.19% (Q2 2025) and -3066.40% (Q3 2025) over five years.
- Per Business Quant data, HUMA's EBITDA Margin in the three quarters before Q2 2026 was -5574.34% (Q1 2026), -6318.63% (Q4 2025) and -3066.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Humacyte | 163.90 Mn | -213.24 Mn | -401,000.00 | -2,076.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2,076.46% |
| Jun 30, 2026 | -6,098.77% |
| Mar 31, 2026 | -5,393.33% |
| Dec 31, 2025 | -6,124.41% |
| Sep 30, 2025 | -2,927.36% |
| Jun 30, 2025 | -9,096.68% |
| Mar 31, 2025 | -4,031.72% |
| Sep 30, 2022 | -70,948.39% |
| Jun 30, 2022 | -1,230.05% |
| Mar 31, 2022 | -8,259.66% |
| Dec 31, 2021 | -10,778.53% |
| Sep 30, 2021 | -7,474.27% |
| Jun 30, 2021 | -2,411.45% |
| Mar 31, 2021 | -11,057.42% |
| Dec 31, 2020 | -10,956.45% |
| Sep 30, 2020 | -1,708.21% |
API Access
Humacyte EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();